Your browser doesn't support javascript.
loading
Genetic deletion of transglutaminase 2 does not rescue the phenotypic deficits observed in R6/2 and zQ175 mouse models of Huntington's disease.
Menalled, Liliana B; Kudwa, Andrea E; Oakeshott, Steve; Farrar, Andrew; Paterson, Neil; Filippov, Igor; Miller, Sam; Kwan, Mei; Olsen, Michael; Beltran, Jose; Torello, Justin; Fitzpatrick, Jon; Mushlin, Richard; Cox, Kimberly; McConnell, Kristi; Mazzella, Matthew; He, Dansha; Osborne, Georgina F; Al-Nackkash, Rand; Bates, Gill P; Tuunanen, Pasi; Lehtimaki, Kimmo; Brunner, Dani; Ghavami, Afshin; Ramboz, Sylvie; Park, Larry; Macdonald, Douglas; Munoz-Sanjuan, Ignacio; Howland, David.
Afiliação
  • Menalled LB; PsychoGenics Inc., Tarrytown, New York, United States of America.
  • Kudwa AE; PsychoGenics Inc., Tarrytown, New York, United States of America.
  • Oakeshott S; PsychoGenics Inc., Tarrytown, New York, United States of America.
  • Farrar A; PsychoGenics Inc., Tarrytown, New York, United States of America.
  • Paterson N; PsychoGenics Inc., Tarrytown, New York, United States of America.
  • Filippov I; PsychoGenics Inc., Tarrytown, New York, United States of America.
  • Miller S; PsychoGenics Inc., Tarrytown, New York, United States of America.
  • Kwan M; PsychoGenics Inc., Tarrytown, New York, United States of America.
  • Olsen M; PsychoGenics Inc., Tarrytown, New York, United States of America.
  • Beltran J; PsychoGenics Inc., Tarrytown, New York, United States of America.
  • Torello J; PsychoGenics Inc., Tarrytown, New York, United States of America.
  • Fitzpatrick J; PsychoGenics Inc., Tarrytown, New York, United States of America.
  • Mushlin R; PsychoGenics Inc., Tarrytown, New York, United States of America.
  • Cox K; PsychoGenics Inc., Tarrytown, New York, United States of America.
  • McConnell K; PsychoGenics Inc., Tarrytown, New York, United States of America.
  • Mazzella M; PsychoGenics Inc., Tarrytown, New York, United States of America.
  • He D; PsychoGenics Inc., Tarrytown, New York, United States of America.
  • Osborne GF; Department of Medical and Molecular Genetics, King's College London, London, United Kingdom.
  • Al-Nackkash R; Department of Medical and Molecular Genetics, King's College London, London, United Kingdom.
  • Bates GP; Department of Medical and Molecular Genetics, King's College London, London, United Kingdom.
  • Tuunanen P; Charles River Discovery Research Services, Kuopio, Finland.
  • Lehtimaki K; Charles River Discovery Research Services, Kuopio, Finland.
  • Brunner D; PsychoGenics Inc., Tarrytown, New York, United States of America.
  • Ghavami A; PsychoGenics Inc., Tarrytown, New York, United States of America.
  • Ramboz S; PsychoGenics Inc., Tarrytown, New York, United States of America.
  • Park L; CHDI Management/CHDI Foundation, Princeton, New Jersey, United States of America.
  • Macdonald D; CHDI Management/CHDI Foundation, Princeton, New Jersey, United States of America.
  • Munoz-Sanjuan I; CHDI Management/CHDI Foundation, Princeton, New Jersey, United States of America.
  • Howland D; CHDI Management/CHDI Foundation, Princeton, New Jersey, United States of America.
PLoS One ; 9(6): e99520, 2014.
Article em En | MEDLINE | ID: mdl-24955833
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transglutaminases / Deleção de Genes / Doença de Huntington / Proteínas de Ligação ao GTP Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transglutaminases / Deleção de Genes / Doença de Huntington / Proteínas de Ligação ao GTP Idioma: En Ano de publicação: 2014 Tipo de documento: Article